Pronóstico del mercado de tratamiento de hematuria en América del Sur y Central hasta 2028: impacto de COVID-19 y análisis regional por tratamiento (fármacos, terapias y otros), indicación (infecciones del tracto urinario, cálculos renales, uretritis, cáncer de sangre, cálculos en la vejiga, cáncer de próstata, cistitis , Trauma, Ejercicio Vigoroso, Poliquistosis Renal, Endometriosis y Menstruación), Tipo (Hematuria Macroscópica, Hematuria Microscópica, Hematuria Idiopática y Hematuria del Jogger), Usuario Final (Hospitales, Clínicas y Centros de Cirugía Ambulatoria, y Otros)
Introducción al mercado
La hematuria es una afección médica en la que se encuentra presencia de sangre en la orina. . Generalmente, la orina no contiene glóbulos rojos y, por lo tanto, esto puede provocar problemas graves que también pueden causar cálculos renales, infecciones del tracto urinario y otras enfermedades hereditarias.
Además, la alta prevalencia de hematuria Se espera que las indicaciones asociadas refuercen el crecimiento del mercado durante el período previsto. Sin embargo, los casos no diagnosticados de indicaciones asociadas limitan el crecimiento del Sur y del Sur. Mercado de tratamiento de hematuria en Centroamérica.
La pandemia de SARS-CoV-2 tuvo un impacto repentino y dramático en la atención médica de la región SCAM. La pandemia de COVID-19 ha cambiado el tratamiento aceptado y rutinario de los casos electivos en la administración hospitalaria. América del Sur y Central no son una excepción. Ahora se aplican estrictos procedimientos de distanciamiento social y los pacientes ingresan en la clínica sin compañía y de forma individual. CoViD-19 ha cambiado la vida cotidiana en casi todo el mundo. En general, la magnitud de esta perturbación se debe a temores individuales y acciones a nivel gubernamental en relación con el impacto local de la pandemia. Sin embargo, puede haber ocasiones en las que se implementen medidas restrictivas en las primeras etapas, cuando se desconoce la rápida evolución del problema, para garantizar la salud de la comunidad. En Argentina, esta fue la situación que paralizó la atención médica programada. Es probable que tales restricciones tengan un impacto negativo en las actividades de investigación y desarrollo, lo que restringiría directamente el crecimiento del mercado del tratamiento de la hematuria en la región.
Visión general y dinámica del mercado
El Sur y el Sur. Se proyecta que el mercado de tratamiento de hematuria en Centroamérica alcance los 65,7 millones de dólares para 2028 desde los 57,8 millones de dólares de 2021; se prevé que crezca a una tasa compuesta anual del 1,8 % de 2021 a 2028. Los avances tecnológicos en dispositivos médicos y procedimientos de diagnóstico han dado lugar a diversas opciones para el tratamiento de las indicaciones asociadas a la hematuria, como cálculos renales, cálculos en la vejiga e infecciones del tracto urinario. Se espera que el uso de tecnologías de tratamiento avanzadas mejore la atención al paciente. Por ejemplo, la implementación de la robótica en las cirugías para el tratamiento de la urolitiasis ha ganado popularidad en los últimos años. Actualmente, Vinci Surgical System, de Intuitive Surgical Inc., se utiliza ampliamente en la realización de cirugías para tratar la urolitiasis. De manera similar, la adopción de intervenciones endourológicas para los cálculos renales ha aumentado significativamente en varios países. También se espera que los avances en las indicaciones asociadas apoyen a los países del Sur y del Sur. Mercado de tratamiento de hematuria en Centroamérica durante el período de pronóstico.
Segmentos de mercado clave
< p>En términos de tipo, el segmento de hematuria macroscópica representó la mayor proporción de los pacientes del Sur y del Sur. Mercado de tratamiento de hematuria de Centroamérica en 2020. En términos de tratamiento, el segmento de medicamentos representó la mayor participación del Sur y del Sur. Mercado de tratamiento de hematuria en Centroamérica en 2020. En términos de indicación, el segmento de infecciones del tracto urinario representó la mayor proporción del mercado del Sur y del Sur. Mercado de tratamiento de hematuria en Centroamérica en 2020. En términos de usuario final, el segmento de hospitales representó la mayor participación del mercado del Sur y del Sur. Mercado de tratamiento de hematuria en Centroamérica en 2020.Principales fuentes y empresas enumeradas
< p>Algunas de las principales fuentes primarias y secundarias a las que se hizo referencia para preparar este informe sobre el mercado del tratamiento de la hematuria en el Sur y el Sur. Centroamérica se encuentran sitios web de empresas, informes anuales, informes financieros, documentos del gobierno nacional y bases de datos estadísticos, entre otros. Las principales empresas que figuran en el informe son AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd y Boehringer Ingelheim International GmbH.Informe Razones para comprar
- Para entender el Sur y el Sur. Panorama del mercado de tratamiento de hematuria en Centroamérica e identificar segmentos de mercado que probablemente garanticen un fuerte retorno
- Para comprender el panorama del mercado en constante cambio y mantenerse a la vanguardia de la competencia
- Planificar eficientemente fusiones, adquisiciones y acuerdos de asociación en el Sur y el Sur. Mercado de tratamiento de hematuria en Centroamérica identificando segmentos con las ventas probables más prometedoras
- Tomar decisiones comerciales informadas a partir de un análisis perspicaz e integral del desempeño del mercado de varios segmentos
- Para obtener una previsión de ingresos de mercado del Sur y del Sur. Mercado de tratamiento de hematuria en Centroamérica basado en varios segmentos para el período 2021-2028
SUR & SEGMENTACIÓN DEL MERCADO DE TRATAMIENTO DE HEMATURIA EN CENTROAMÉRICA
Por < span>Tratamiento
- Fármacos
- Terapias
- Otros
Por indicación
- Infecciones del tracto urinario
- Cálculos renales
- Uretritis
- Cáncer de sangre
- Cálculos en la vejiga
- Cáncer de próstata
- Cistitis
- Trauma
- Ejercicio vigoroso
- < span>Enfermedad Renal Poliquística
- Endometriosis
- Menstruación
Por Tipo
- Hematuria macroscópica
- Hematuria microscópica
- Hematuria idiopática
- Hematuria del corredor
Por usuario final
- Hospitales
- Clínicas
- Centros de Cirugía Ambulatoria (ASC)
- Otros
Por país
- Sur y Asia. Centroamérica
- Brasil
- Argentina
- Resto del Sur y América Centroamérica
Empresas mencionadas
- AstraZeneca
- Compañía Bristol-Myers Squibb
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- < span>Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Hematuria Treatment Market – By Treatment
1.3.2 South & Central America Hematuria Treatment Market – By Indication
1.3.3 South & Central America Hematuria Treatment Market – By Type
1.3.4 South & Central America Hematuria Treatment Market – By End User
1.3.5 South & Central America Hematuria Treatment Market – By Country
2. South & Central America Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – South & Central America Analysis
6.1 South & Central America Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 South & Central America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 South & Central America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 South & Central America Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 South & Central America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. South & Central America Hematuria Treatment Market – Geographic Analysis
11.1 South and Central America: Hematuria Treatment Market
11.1.1 Overview
11.1.2 South and Central America: Hematuria Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.4 South and Central America: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.5 South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.6 South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7 South and Central America: Hematuria Treatment Market Share by Country – 2021 & 2028, (%)
11.1.7.1 Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.1.1 Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.1.2 Brazil Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.3 Brazil: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.7.1.4 Brazil Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.5 Brazil Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.2 Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.2.1 Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.2.2 Argentina Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.3 Argentina: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.7.2.4 Argentina Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.5 Argentina Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
11.1.7.3 Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.3.1 Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
11.1.7.3.2 Rest of South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.3 Rest of South and Central America: Hematuria Treatment Market, by Indication – 2020–2028 (USD Million)
11.1.7.3.4 Rest of South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.5 Rest of South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 South & Central America: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 2. South and Central America Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 3. South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million
Table 4. South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Thousand)
Table 5. Brazil Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. Brazil Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 7. Brazil Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Brazil Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 10. Argentina Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. Argentina Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Argentina Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of South and Central America Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of South and Central America Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of South and Central America Hematuria Treatment Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of South and Central America Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. South & Central America Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. Brazil to Show Significant Growth During Forecast Period
Figure 5. South & Central America Hematuria Treatment Market, Industry Landscape
Figure 6. South & Central America PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. South & Central America Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. South & Central America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. South & Central America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. South & Central America Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. South & Central America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. South and Central America: Hematuria Treatment Market, By Key Country – Revenue (2021) (USD Million)
Figure 37. South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 38. South and Central America: Hematuria Treatment Market Share by Country – 2021 & 2028, (%)
Figure 39. Brazil: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 40. Argentina: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 41. Rest of South and Central America: Hematuria Treatment Market- Revenue and Forecast To 2028 (USD Million)
Figure 42. Impact Of COVID-19 Pandemic in South & Central America Country Markets
Figure 43. Growth Strategies Done by the Companies in the Market, (%)
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.